HCWB hcwbiologics.com: Forvard P/S multiplikatori
Biotexnologiya gigantlari bilan bemorlar kirish imkoniyati uchun olib borilayotgan shiddatli raqobat HCW Biologics Inc. (HCWB) uchun xatarlarni yuzaga keltirmoqda. Forward P/S ko'rsatkichi joriy bozor dinamikasini aks ettiradi, bunda ushbu metrika 0.30 qiymatida qat'iy belgilangan. Narxlar barqarorligi immunologlarning kuchli jamoasi va saxovatli aksiyalar opsionlari tomonidan qo'llab-quvvatlanmoqda. O'sish istiqbollari sezilarli investitsiya kapitalini jalb qilish uchun yangi terapevtik platformalarning joriy etilishiga asoslangan.
hcwbiologics.com (HCWB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati HCW Biologics Inc.|HCWB - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati HCW Biologics|HCWB - Kompaniya qarzlari|Balans kapitallashuviga qarzlar HCW Biologics|HCWB - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi HCW Biologics|Tezkor likvidlik hcwbiologics.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
HCWB - Kompaniyaning sof foydasi|Kutilayotgan foyda HCW Biologics Inc.|HCWB - Kapitalizatsiyaning foydaga nisbati|Forvard P/E multiplikatori HCW Biologics|HCWB - Narxning sof foyda o‘sishiga nisbati|EV/EBITDA multiplikatori HCW Biologics|HCWB - Amortizatsiya chegirilmasdan oldingi operatsion daromad|Bir aksiya uchun sof foyda (EPS TTM) HCW Biologics|HCWB - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi hcwbiologics.com|HCWB - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi HCW Biologics Inc.
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahliliyoti:HCW Biologics Inc HCWB
HCW Biologics Inc. (HCWB) kompaniyasining bozor tebranishlariga chidamliligi toza xonalar modernizatsiyasining samaradorligi va immunoterapiya ishlab chiqarish uchun joriy quvvatdan foydalanish darajasi bilan ta'minlanadi. Kompaniyaning modellashtirilgan P/S koeffitsiyenti joriy bozor kapitalizatsiyasini kutilayotgan savdo hajmi bilan solishtiradi, bu esa investorlarga ushbu grafikdagi narx harakatlari orqali vaqtincha yuzaga kelgan ommaviy vahimani aktivning fundamental zaiflashishidan ajratish imkonini beradi va shu orqali biznesning ob'ektiv baholanishini ta'minlaydi.
Raqobatdosh kompaniyalar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ADMA (ADMA Corp)|PTGX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori immunovant.com|Forvard narx/daromad multiplikatori KNSA|Forvard narx/daromad multiplikatori Grifols SA (GRFS)|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|CLDX (Celldex Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|biocryst.com - Narxning prognoz qilingan daromadga nisbati|Vera Therapeutics - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Dianthus Therapeutics Inc DNTH|Pharvaris Corp (PHVS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati AbCellera Corp (ABCL)|Narxning prognoz qilingan daromadga nisbati Tourmaline Bio, Inc.|Narxning prognoz qilingan daromadga nisbati PGEN|Narxning prognoz qilingan daromadga nisbati Pharming Group (PHAR)|NKTR - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori UPB (Upstream Bio Corp)|Prognoz narxning daromadga nisbati Zenas Corp|Immunome, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati gossamerbio.com GOSS|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna, Inc.|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals Inc|Savara Pharma (SVRA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori RIGL (Rigel Pharmaceuticals)|ANAB (anaptysbio.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ATXS (Astria Therapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc (ENGN)|RAPT - Narxning prognoz qilingan daromadga nisbati|JBIO (Aerovate Therapeutics Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ACRS: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori kyvernatx.com|Forvard narx/daromad multiplikatori TLSA|Cabaletta Bio Inc. (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori VTYX|THTX (Theratechnologies, Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|ELDN - Forvard narx/daromad multiplikatori|AGEN: Forvard narx/daromad multiplikatori|Climb Bio Inc. (CLYM) - Forvard narx/daromad multiplikatori|ZURA: Forvard P/S multiplikatori|ATYR (aTyr Pharmaceuticals) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Ikena Oncology, Inc. - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori STTK|EQ (equilliumbio.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|ATRA - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx IFRX (InflaRx N.V.)|X4 Pharmaceuticals, Inc. (XFOR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Adicet Bio, Inc.|CELU (Celularity Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori INmune Bio Corporation|Forvard narx/daromad multiplikatori BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SABS (SAB Biotherapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Akari Therapeutics PLC (AKTX)|ENLV - Narxning prognoz qilingan daromadga nisbati|Q32 Bio Inc. (QTTB) - Forvard narx/daromad multiplikatori|GeoVax Labs, Inc. (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori edesabiotech.com|Forvard narx/daromad multiplikatori IBIO|Forvard P/S multiplikatori Carisma Tx|Narxning prognoz qilingan daromadga nisbati XTL Biopharmaceuticals, Ltd. (XTLB)|boltbio.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. (AIM) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Aditxt Corp - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx GRI (GRI Bio Inc)|XRTX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Vyome Therapeutics|Forvard narx/daromad multiplikatori REVB|Forvard narx/daromad multiplikatori indaptusrx.com (INDP)|Forvard narx/daromad multiplikatori SCNI (Scinai Immunotherapeutics Ltd.)|CALI (calcimedica.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Allakos Inc - Narxning prognoz qilingan daromadga nisbati|HOOKIPA - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ocean Biomedical Inc (OCEA)|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Narxning prognoz qilingan daromadga nisbati THRD
